Truven Health in an opinion brief shared the payer perspective on outcomes-based contracts (OBCs), and offered some insights as to what steps the industry can take to make them “meaningful, sustainable and scalable.”
According to the brief, payer executives interviewed mostly said they were “overwhelmed” by the sheer volume of value-based initiatives in which they’ve been asked to participate.
All payers in the interview process, however, all expressed growing concerns over the increasing costs of prescription drugs.
“OBCs were mentioned by payers as one of the largest potential ways to mitigate the spend on prescription drugs,” the brief says. “In addition, payers are exploring the use of other innovative contracts, such as indication-specific pricing or requiring additional patient support services to help mitigate the financial impact.”
